TGF beta 1 Protein, Cynomolgus, Recombinant (His Tag)
Product Specifications
Background
TGF-beta 1 is a member of the transforming growth factor beta (TGF-beta) family. The transforming growth factor-beta family of polypeptides are involved in the regulation of cellular processes, including cell division, differentiation, motility, adhesion and death. TGF-beta 1 positively and negatively regulates many other growth factors. It inhibits the secretion and activity of many other cytokines including interferon-γ, tumor necrosis factor-alpha and various interleukins. It can also decrease the expression levels of cytokine receptors. Meanwhile, TGF-beta 1 also increases the expression of certain cytokines in T cells and promotes their proliferation, particularly if the cells are immature. TGF-beta 1 also inhibits proliferation and stimulates apoptosis of B cells, and plays a role in controlling the expression of antibody, transferrin and MHC class II proteins on immature and mature B cells. As for myeloid cells, TGF-beta 1can inhibit their proliferation and prevent their production of reactive oxygen and nitrogen intermediates. However, as with other cell types, TGF-beta 1 also has the opposite effect on cells of myeloid origin. TGF-beta 1 is a multifunctional protein that controls proliferation, differentiation and other functions in many cell types. It plays an important role in bone remodeling as it is a potent stimulator of osteoblastic bone formation, causing chemotaxis, proliferation and differentiation in committed osteoblasts. Once cells lose their sensitivity to TGF-beta1-mediated growth inhibition, autocrine TGF-beta signaling can promote tumorigenesis. Elevated levels of TGF-beta1 are often observed in advanced carcinomas, and have been correlated with increased tumor invasiveness and disease progression.
Overview
A DNA sequence encoding the cynomolgus TGFB1 (Met1-Ser390) was expressed with a polyhistidine tag at the C-terminus.
Gene Name
Transforming growth factor, beta 1
Expression System
HEK293 Cells
Tag
C-His
Field of Research
Early Mesodermal Lineage Markers Cancer Drug Targets
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
Purity
> 95 % as determined by SDS-PAGE.
Activity
1. Measured by its binding ability in a functional ELISA. 2. Immobilized Cynomolgus TGFB1-His at 10 μg/mL (100 μL/well) can bind Cynomolgus TGFBR2-Fc (Cat:PK54039M4) . The ECof Cynomolgus TGFBR2-Fc (Cat:PK54039M4) is 28-56 ng/mL.
Form
Lyophilized
Buffer
Lyophilized from sterile PBS, pH 7.4. Please contact us for any concerns or special requirements. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization. Please refer to the specific buffer information in the hard copy of CoA.
Function
TGF beta Family proteins, Immunotherapy proteins, Cytokine Proteins, epigenetic proteins, Growth Factor proteins, Biomarker Proteins, Cell Therapy proteins, Biological Target proteins, Diagnostic proteins
Molecular Weight
The recombinant cynomolgus TGFB1 consists 372 amino acids and predicts a molecular mass of 42.7 kDa.
Storage Conditions
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise. Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.
Symbol
TGFB1
Species
Cynomolgus
AA Sequence
Met1-Ser390
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog